Clinical Trial Update: A Phase 2 Study of HSK47388 Tablets to Evaluate the Efficacy and Safety in Patients With Moderate-to-Severe Plaque Psoriasis [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating the efficacy and safety of HSK47388 tablets in patients with moderate-to-severe plaque psoriasis; the study status is NOT_YET_…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Plaque Psoriasis

Drugs mentioned

• HSK47388

Snippet

Sponsor: Haisco Pharmaceutical Group Co., Ltd. | Conditions: Plaque Psoriasis | Phase 2 | Status: NOT_YET_RECRUITING